@article{PMID:32330875, author = {Nwosu, Z. C. and Pioronska, W. and Battello, N. and Zimmer, A. D. and Dewidar, B. and Han, M. and Pereira, S. and Blagojevic, B. and Castven, D. and Charlestin, V. and Holenya, P. and Lochead, J. and De La Torre, C. and Gretz, N. and Sajjakulnukit, P. and Zhang, L. and Ward, M. H. and Marquardt, J. U. and di Magliano, M. P. and Lyssiotis, C. A. and Sleeman, J. and Wolfl, S. and Ebert, M. P. and Meyer, C. and Hofmann, U. and Dooley, S.}, title = {Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance.}, journal = {EBioMedicine}, year = {2020}, volume = {54}, pages = {102699}, url = {http://www.ncbi.nlm.nih.gov/pubmed/32330875}, }